Genes2Me Private Limited

G2M is a global IVD innovator offering 30+ CE-IVD approved NGS panels, automated library preparation system, POCT instruments, and extraction kits across oncology, AMR, reproductive health, and infectious diseases. Our flagship OnePCR delivers 50+ CE-IVD approved assays, including sepsis detection from whole blood in under 2 hours. G2M combines advanced disease detection with competitive pricing for accessible, high-quality patient care.